← Open Payments lookup

CHARLES FLYNN: Open Payments

NPI 1609391598 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$657 in 31 payments from 11 companies in 2025. Trend: 2023 $588 · 2024 $1,255 · 2025 $657

Food & beverage: $657
CompanyPaymentsAmount
Celgene Corporation9$176
Novartis Pharmaceuticals Corporation8$141
ABBVIE INC.3$96
PFIZER INC.3$62
TAIHO ONCOLOGY, INC.2$34
Regeneron Healthcare Solutions, Inc.1$32
E.R. Squibb & Sons, L.L.C.1$30
Merck Sharp & Dohme LLC1$25
AstraZeneca Pharmaceuticals LP1$24
SUN PHARMACEUTICAL INDUSTRIES INC.1$19

Products named: REBLOZYL, IBRANCE, KISQALI, IMBRUVICA, LUTATHERA, EPKINLY, Fabhalta, LONSURF.

Industry payments across SC — which companies pay providers there.